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Current clinical imaging methods face limitations in the detection and correct characterization 
of different subtypes of renal cell carcinoma (RCC), while these are important for therapy and 
prognosis. The present study evaluates the potential of grating-based X-ray phase-contrast computed 
tomography (gbPC-CT) for visualization and characterization of human RCC subtypes. The imaging 
results for 23 ex vivo formalin-fixed human kidney specimens obtained with phase-contrast CT were 
compared to the results of the absorption-based CT (gbCT), clinical CT and a 3T MRI and validated using 
histology. Regions of interest were placed on each specimen for quantitative evaluation. Qualitative 
and quantitative gbPC-CT imaging could significantly discriminate between normal kidney cortex 
(54 ± 4 HUp) and clear cell (42 ± 10), papillary (43 ± 6) and chromophobe RCCs (39 ± 7), p < 0.05 
respectively. The sensitivity for detection of tumor areas was 100%, 50% and 40% for gbPC-CT, 
gbCT and clinical CT, respectively. RCC architecture like fibrous strands, pseudocapsules, necrosis or 
hyalinization was depicted clearly in gbPC-CT and was not equally well visualized in gbCT, clinical CT 
and MRI. The results show that gbPC-CT enables improved discrimination of normal kidney parenchyma 
and tumorous tissues as well as different soft-tissue components of RCCs without the use of contrast 
media.
Most renal lesions are incidentally detected in ultrasound or computed tomography (CT) often presenting with-
out clinical symptoms. Thereby, renal cell carcinoma (RCC) account for 2–3% of all adult cancers worldwide1. The 
common subtypes of sporadic RCC are clear cell (ccRCC; 70–85%), papillary (pRCC; 7–15%) and chromophobe 
RCC (chrRCC; 5–10%)2. Each RCC subtype has a different prognosis, metastatic rate and differs in the response 
to targeted therapies3. Differentiation of renal lesions is limited for non-enhanced CT due to its low soft-tissue 
contrast4. The use of contrast agents improves the detection and discrimination of different RCC subtypes using 
multiphasic CT4–6 and magnetic resonance imaging (MRI)7,8. Iodine-based contrast agents can cause acute renal 
failure, anaphylactic reactions or thyrotoxic crisis while gadolinium-based contrast media can cause nephrogenic 
systemic fibrosis. Contraindications for MRI are cardiac pacemakers and patients with claustrophobia.
For preoperative histological diagnosis percutaneous renal tumor biopsies are often used, but potential post-
bioptic complications9 lead to limited acceptance.
Phase-contrast computed tomography (PC-CT) is a promising new X-ray-based imaging method. In con-
trast to conventional CT, where the attenuation of X-rays is measured, the refraction of the X-ray beam that 
occurs when the beam passes through tissue is visualized in phase-contrast imaging10. Different techniques can be 
used to derive the phase-contrast signal, e.g. propagation-based, analyzer-based or crystal-interferometer-based 
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methods, however, these approaches face some limitations with respect to the implementation into a clinical 
environment11. Another method is the grating interferometry, which simultaneously yields three complimen-
tary signals – the conventional attenuation, a phase-contrast and a dark-field image. Pfeiffer et al.12 showed that 
conventional polychromatic X-ray sources can be used for phase-contrast imaging with a three gratings interfer-
ometer, which is a prerequisite for clinical application. With this approach, previous studies showed an increased 
soft-tissue contrast, e.g. in breast specimens13–15, atherosclerotic plaques16,17, liver lesions18, murine kidneys with 
and without renal ischemia19 and other soft-tissue components20,21.
The purpose of this ex vivo study was to evaluate the potential of grating-based PC-CT (gbPC-CT) imaging 
for the visualization of tumor architecture and for the characterization of different RCC subtypes in comparison 
to attenuation-based CT and MRI and to correlate the results with histopathology as the standard of reference.
Results
Normal kidney parenchyma. GbPC-CT of normal human kidney allowed a qualitative and quantitative 
differentiation between cortex (54 ± 4 HUp) and medulla (44 ± 3 HUp; p < 0.05) and showed a good visual agree-
ment to T2w-MRI and histologic slices (Fig. 1). Vessels were clearly distinguished from kidney parenchyma. In 
gbCT (Fig. 1) and clinical CT (clinCT; not shown), discrimination of cortex or medulla was not possible.
Qualitative Analysis of Renal Cell Carcinomas. Qualitative image analysis showed that gbPC-CT imag-
ing allowed a reliable differentiation of tumorous tissue of ccRCCs, pRCCs and chrRCCs from normal renal 
cortex (Figs 2–4). Tumorous tissue showed visually lower phase-contrast intensity, a loss of normal cortical or 
medullar structure and absent normal vessels in comparison to normal kidney.
The sensitivity was 100% for detection of tumor areas on gbPC-CT and MRI as verified by histology. Tumor 
boundaries could be differentiated from normal kidney, and showed excellent visual agreement with histological 
slices. Images of attenuation-based CTs showed a significantly lower sensitivity for detection and discrimination 
of tumor suspicious areas from normal parenchyma (gbCT: 50%; clinCT: 40%). A clear delineation of tumor 
boundaries was not possible (Figs 2–4).
Figure 1. Normal human kidney sample imaged with phase-contrast CT, grating-based attenuation-based 
CT, T2-w magnetic resonance imaging and histologic slice (coronal slice). Good visual agreement between 
the histology ((A); HE-staining) and grating-based phase-contrast CT ((B); gbPC-CT) showed a higher soft-
tissue contrast and a clear discrimination of renal vessels (arrow) and between the cortex (*) with higher and 
the medulla (**) with lower phase-contrast signal with good comparison to T2-w magnetic resonance imaging 
(MRI) (D). Imaging with grating-based attenuation-based CT (gbCT) from the same setup (C) had an obvious 
lower soft-tissue contrast.
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GbPC-CT showed a high sensitivity for detection of soft-tissue components (Table 1, Fig. 5). Small dot-like 
microbleeding and diffuse hemorrhage showed a high signal and a wide distribution throughout the tumorous 
tissue. Fibrous strands and pseudocapsules were detected as linear contrast-rich bands that can be found through-
out the low-signal tumorous tissue and surrounding the tumor boundaries, respectively (Fig. 5). These tissue 
components could not be visualized with gbCT and clinCT (Table 1). Areas of necrosis showed a higher and 
hyalinization a lower signal in comparison to tumorous tissue (Fig. 5), with a lower detection rate in gbPC-CT, 
gbCT and MRI in comparison to histology and with the lowest sensitivity in clinCT (Table 1).
Small dot-like calcifications (microcalcification) were clearly visualized in gbPC-CT. Larger calcifications 
showed the highest soft-tissue signals with small surrounding artifacts and an excellent visualization in gbPC-CT 
and gbCT and a lower detection rate in clinCT (Table 1). Fat depositions were clearly visualized in all imaging 
methods due to the lowest signals (Figs 2–4).
In good agreement with the histological examination, most ccRCCs (75%) had a heterogeneous appearance 
in gbPC-CT with detection of hyalinization, necrotic areas, local and diffuse hemorrhage, small calcifications, 
sinusoid-like tumor vessels and cystic changes. Papillary RCC and chrRCCs were more homogeneous (71% 
and 100%, respectively) with linear, contrast-rich bands in the low-signal tumor tissue corresponding to fibrous 
strands and pseudocapsules and displayed fewer calcifications than ccRCC. Diffuse hemorrhage, hyalinization, 
necrosis or cystic changes were not seen in chrRCCs. The occurrence of the different tissue components in each 
RCC subtype is visualized in Fig. 6.
No intratumoral tissue components like fibrous strands, pseudocapsules or microbleedings were visualized 
with gbCT and clinCT. About half of the ccRCC samples showed a hypodense and inhomogeneous tissue appear-
ance with large calcifications (3/8) and diffuse hemorrhage (2/8) detected in clinCT and gbCT, the other samples 
showed hyperdense tissues without a possible differentiation from normal kidney. Homogeneous hypodense 
tissues were detected in pRCC and chrRCC subtypes in gbCT (4/7 and 2/5, respectively) and clinCT (3/7 and 2/5, 
respectively) with large calcification in one chrRCC sample.
Quantitative Analysis of Renal Cell Carcinomas. Tumorous tissue of ccRCCs (n = 8), pRCCs (n = 7) 
and chrRCCs (n = 5) could be differentiated from normal renal cortex (n = 6) due to a significantly lower signal 
Figure 2. Clear cell renal cell carcinoma sample imaged with phase-contrast CT, grating-based and clinical 
CT and MRI with corresponding histological slice. Good visual agreement between histological slice ((A); 
HE-staining) and corresponding phase-contrast CT image ((B); gbPC-CT) with distinct differentiation of large 
and small tumor nodules with low signal (**), diffuse intratumoral bleedings (arrow), as well as a fatty area 
(arrowhead) and a large vessel at the bottom of the slice. GbPC-CT (B) showed a superior visualization of tumor 
boundaries and different tumor nodules (**) than with gbCT (C) and clinical CT (F), which could only detect 
fat (arrowhead) and soft-tissue (area of hyperdensity). GbPC-CT imaging (A) showed a better depiction of the 
tumor components like intratumoral bleeding than in MRI images (D and E) due to susceptibility artifacts.
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(Fig. 6 B; p < 0.05). A quantitative differentiation of renal medulla and tumorous tissue and a differentiation 
between ccRCC and pRCC or chrRCC was not possible (Fig. 6B).
Variable tumor tissue components were detected in gbPC-CT due to significant different signal intensities. 
Hemorrhage showed significantly higher phase-contrast signal (80 ± 9 HUp) than pseudocapsule (66 ± 8 HUp), 
fibrotic strands (57 ± 5 HUp), and necrosis (54 ± 5 HUp). Compared to these, hyalinization showed significantly 
lower signal intensity (p < 0.05, respectively; Fig. 6). Calcifications with the highest densities (280 ± 199 HUp) as 
well as fat (− 60 ± 10 HUp) with the lowest density could be clearly differentiated from soft tissue. Compared to 
MRI, where calcifications and microbleedings cannot be separated due to same susceptibility artifacts, gbPC-CT 
showed a good discrimination between hemorrhage (80 ± 9 HUp) and larger calcifications (> 290 HUp) with 
small artifacts.
Discussion
Our results of this ex vivo feasibility study indicate that grating-based X-ray phase-contrast imaging is able to qual-
itatively and quantitatively discriminate normal kidney from renal cell carcinomas superior to absorption-based 
CTs without application of contrast media. Our findings are in good agreement with a recent study19 showing 
an improved evaluation of normal and ischemic renal parenchyma in murine kidneys using synchrotron-based 
phase-contrast imaging. Compared to previous studies22,23, our measurements for cortex and medulla of healthy 
human renal samples were elevated, which may occur due to longer storage times (see Willner et al.23).
In terms of depiction and quantitative differentiation of fine intratumoral structures we could demonstrate 
that gbPC-CT showed a good agreement to histopathology and is superior to MRI and also to unenhanced 
absorption-based CTs independent from the effective pixel size (clinCT: 400 vs. gbCT: 100 μ m).
The detection and characterization of incidentally imaged renal lesions on unenhanced CT remains difficult 
due to the method’s low soft-tissue contrast4. Additionally, unenhanced CT values of different RCC subtypes 
showed divergent measurements4,24. Contrast enhanced multiphasic CT and MRI images are used in clinical 
routine to diagnose RCC and to define the subtype5,8. The accuracy of discriminating ccRCC from papillary 
and chromophobe RCC was reported with 85% and 84% in multiphasic CT4. Also differentiation of malignant 
Figure 3. Papillary renal cell carcinoma sample imaged with phase-contrast CT, grating-based and 
clinical CT and MRI with corresponding histological slice. A perfect match of the histological slice (A) and 
the phase-contrast (gbPC-CT) image (B) was seen with a clear discrimination of the normal cortex (*) with a 
higher phase-contrast signal and the homogeneous tumor area (**) with lower signal in gbPC-CT. Additionally, 
gbPC-CT could depict the pseudocapsule surrounding the tumor with a higher signal (arrowhead) than 
cortex, a micrometastasis in the cortex (arrow) as well as small linear fibrous strands. In grating-based CT 
(gbCT) (C) and clinical CT (F), only perirenal fat was visible (hypodense), soft-tissue components could not be 
differentiated. When correlating gbPC-CT (B) with MR images (D,E), a superior discrimination of tumor and 
normal kidney is seen in the phase-contrast image.
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subtypes is getting more difficult, when tumor size decreases25. But both approaches, CT and MRI, face significant 
limitations. In this context, gbPC-CT may improve diagnostics without any use of contrast agents in future.
In good agreement to histology, clear cell carcinomas showed a trend towards a more heterogeneous appear-
ance with diffuse hemorrhages, hyalinization, necrosis and sinusoidal vessels in contrast to pRCC and chrRCC 
in gbPC-CT. Papillary RCC showed a higher detection of fibrous strands, pseudocapsules and microbleedings 
as well as diffuse hemorrhage and cystic changes. Chromophobe RCCs were the most homogeneous tumors 
with fibrous strands and microbleeding without detection of hyalinization or necrosis. This detailed informa-
tion obtained with gbPC-CT may further be used in addition to CT or MRI images to elevate the accuracy 
Figure 4. Chromophobe renal cell carcinoma sample imaged with phase-contrast CT, grating-based and 
clinical CT and MRI with corresponding histological slice. A good correlation was seen between histology 
(A) and phase-contrast imaging (gbPC-CT; (B)) for clear detection of normal kidney (*) with significant higher 
signal (p < 0.05) and the homogeneous tumor with lower signal (**). In the middle, a stripe of fat with low signal 
(arrow) is clearly visualized with all imaging techniques. In comparison to gbPC-CT, grating-based CT (gbCT) 
(C), clinical CT (F) and MRI (D,E) could only show a marginal visible difference between normal and tumorous 
tissue.
gbPC-CT/Histo gbCT/Histo clinCT/Histo MRI/Histo
Fibrous strands 15/15 0/15 0/15 4/15
Pseudocapsule 8/9 0/ 9 0/9 6/9
Calcification 9/17 17/17 4/17 *
Microbleeding 10/11 0/11 0/ 11 *
Diffuse hemorrhage 5/5 3/5 2/5 5°/5
Hyalinization 6/8 6/8 2/8 6/8
Necrosis 2/3 0/3 0/3 1/3
Table 1.  Detection of different tumor components in gbPC-CT, gbCT, clinCT and MRI compared 
with histopathologic findings. Note. – detection in the different modalities was determined according to 
histopathological findings. *Small susceptibility artifacts in susceptibility weighted images (SWI) in 17 samples. 
°large hypointense areas. gbPC-CT – grating-based phase-contrast computed tomography; gbCT – grating-
based computed tomography; clinCT – clinical computed tomography; MRI – magnetic resonance imaging; 
Histo – histological findings.
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of diagnosing RCC subtypes in the future. However, a separation of RCC subtypes based only on quantitative 
HUp-values cannot be achieved.
Histology has a significantly higher spatial resolution than gbPC-CT, clinCT or MRI, and numerous addi-
tional tests like immunochemistry are available. For example, a histological diagnosis of chromophobe tumor can 
only be made after Hale’s staining.
Limitation of this study is that gbPC-CT is currently available only in preclinical settings. Furthermore, 
the ex vivo RCC samples in this study were scanned without contrast media in the PC-CT setup, clinical CT 
Figure 5. Visual comparison between histological slices and grating-based PC-CT images. Histological 
slices (HE-staining) (A,C,E,G) showed a good visual agreement with phase-contrast images (B,D,F,H) for 
visualization of different tumor tissue components (arrows) like fibrous strands (A,B), pseudocapsule (arrow) 
and hemorrhage (arrowhead) (C,D), diffuse necrotic areas with higher signal (*) and tumor tissue with lower 
phase-contrast signal (**) (E,F) as well as sinusoidal-vessels (arrow) and hyalinization (dotted line) (G,H).
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and MRI, which could have decreased the sensitivity. Finally, Hounsfield units of attenuation-based CTs are 
energy-dependent20 and, therefore, a direct quantitative comparison between the two CTs (gbCT acquired at 40 
and clinCT at 120 kVp) cannot be performed. Currently, the field-of-view of gbPC-CT is limited by the size of the 
available gratings while a previous study by Willner et al.26 could demonstrate that the grating-based method can 
also work at higher, clinically relevant energies.
The resolution of the gbPC-CT in this study was significantly higher than the one typically used in clin-
ical imaging. Such a high resolution has no limitation for histopathological workup scans, but it is not com-
patible with clinical patient imaging. In general, it can be expected that also for clinically relevant resolutions, 
phase-contrast imaging will still provide a superior contrast between different soft tissue subtypes compared to 
the conventional attenuation imaging27,28. However, at lower image resolution the border delineation between 
e.g. healthy and tumorous tissue will be more challenging. This effect is highlighted in Fig. 7, where the sample 
Figure 6. Occurrence of tissue components and quantification of different tumors and soft-tissue 
components in renal cell carcinoma subtypes. Data obtained from gbPC-CT in good correlation with 
histology. (A) Bar graphs visualizing the percentaged occurrence visualized in grating-based phase-contrast CT 
in agreement with histologic slices of various tumor tissue components like fibrous strands, pseudocapsules, 
calcifications, hyalinization, necrotic areas and sinusoidal-vessels in the different renal cell carcinoma subtypes. 
(ccRCC = clear cell; pRCC = papillary; chrRCC = chromophobic renal cell carcinoma). (B) In grating-based 
phase-contrast CT, the cortex of normal human kidney showed significant higher HUp-values than medulla 
(*means p < 0.05). A significant difference of quantitative phase-contrast values was seen between cortex and 
the tumor tissue of all renal cell carcinoma (RCC) subtypes (*means p < 0.05, respectively). (C) Significant 
quantitative difference of HUp-values in phase-contrast imaging was seen between the different tumor 
components. The highest values were seen for hemorrhage, lower for pseudocapsule, fibrosis and necrosis and 
the lowest in hyalinization areas with a significant difference from each other (p < 0.05, respectively).
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from Fig. 3 is presented at different effective resolutions, obtained through retrospective image binning. While it 
is possible to tell the difference between healthy and tumorous tissue even at 500 × 500 μ m2 resolution, the exact 
border outline is not as obvious as it is in the case of 100 × 100 μ m2 resolution.
The high resolution used in this study also implied that the dose delivered to the samples is far beyond any 
clinical CT scan. The dose level in this study is better comparable to a microCT. Our result correlates well with 
earlier microCT studies that showed even at an elevated dose level, absorption contrast was not able to yield the 
same soft tissue contrast as obtained through phase-contrast imaging16,19,29.
All in all, this proof-of-principle study demonstrates that gbPC-CT has the potential to provide diagnostic 
value in evaluation of renal pathology even without the use of contrast agent. In the future it could be used to 
gain additional information of the tumor composition ex vivo after partial or total nephrectomy before histolog-
ical workup. Unlike destructive histology that only provides two-dimensional information of representative and 
macroscopically suspicious regions, gbPC-CT could visualize the whole extent of the tumor in three-dimensions. 
Thus, introduction of a sample gbPC-CT scanner to clinical routine could help to speed up and elevate the cer-
titude of the pathological evaluation. Furthermore, gbPC-CT could be used for tumor tissue characterization in 
ex vivo imaging studies, as previously shown for pancreatic cancer29 on animal models. Introduction of clinical 
phase-contrast CT scanners would benefit the diagnosis of RCCs. This could be also of future interest to differ-
entiate benign lesions like oncozytomas or angiomyolipomas from RCCs or detect micrometastases in renal 
parenchyma in in vivo imaging additionally to CT or MRI. However, this step is not straightforward and requires 
major technical efforts.
One of the major technical challenges that would have to be overcome is the size of the field of view, which is 
currently severely limited by the size of the available gratings. However, recent advances in the field of grating pro-
duction provide promise that this obstacle may be overcome30. Furthermore, phase-contrast CT requires acquisi-
tion of images with different relative grating positions31 which implies longer scan times. It has been reported that 
as few as two grating positions are enough to obtain the phase-contrast and the conventional absorption signal32. 
Thus, it means that the total scan time would increase by a little bit more than a factor of two compared to the 
currently used protocols. A scan time increase by a factor of two seems to be reasonable for renal imaging, though 
the risk of movement artifacts due to prolonged acquisition time increases. Moreover, in humans, the overlaying 
structures may complicate the acquisition of phase contrast. Especially such highly absorbing structures as the 
ribcage can cause severe image artifacts. Therefore, it is necessary to consider advanced iterative reconstruction 
algorithms as has been reported by Hahn et al.33. Further challenges that need to be resolved before the method 
can be translated to human imaging include the technical feasibility of placing a grating interferometer onto a 
very compact gantry, and its stability during very fast rotation.
Several studies34–36 have reported in the past that a clinCT scan performed at 80 kVp instead of 120 kVp could 
be beneficiary for the visualization of pathologies especially for thin patients. Therefore, future studies should 
seek to analyze how a 80 kVp clinCT scan could help better diagnose RCCs in patients and compare the results 
to gbPC-CT imaging.
Compared to attenuation-based CTs, gbPC-CT allowed for improved visualization of soft-tissue and tumor 
tissue architecture and improved discrimination of normal kidney and tumorous tissue of ex vivo samples of 
renal cell carcinoma subtypes without application contrast media with an excellent visual agreement to histopa-
thology and MRI. GbPC-CT has the potential to improve renal imaging and may further be used during histo-
pathological workup of large tumors to visualize diagnostically valuable tissue sections with a three-dimensional 
whole-sampling imaging.
Material and Methods
Samples. This retrospective experimental ex vivo study was approved by the local ethics commit-
tee (Ethikkomission der Universität München, München) and carried out in accordance to the international 
Declaration of Helsinki. Informed consent was obtained from all patients. Indication to partial or total nephrec-
tomy followed recommendation of the interdisciplinary tumor conference. After surgical tumor excision, rep-
resentative tumor tissue sections of 3 cm maximum diameter and 10 cm maximum length were selected by an 
experienced pathologist and put into 50 ml plastic containers in 4% formaldehyde solution.
Figure 7. Influence of the image resolution on the gbPC-CT imaging results. GbPC-CT slice of a papillary 
renal cell carcinoma sample from Fig. 3 shown at different effective resolutions: (A) 100 × 100 μ m2, (B) 
300 × 300 μ m2, (C) 400 × 400 μ m2, (D) 500 × 500 μ m2. Different effective resolutions were obtained through 
retrospective binning of the original data.
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In total, 23 human renal ex vivo samples were collected including 8 clear cell (ccRCC; 1x T2, 7x T3; mean 
diameter: 9 cm [5.8–16 cm]), 7 papillary (pRCC; 2x T1, 2x T2, 3x T3; mean diameter: 12 cm [5.5–23 cm]) and 
5 chromophobe RCCs (chrRCC; 1x T1, 2x T2, 2x T3; mean diameter: 6.5 cm [3.2–10 cm]) as well as 3 healthy 
kidney sections after total nephrectomy.
Grating-based X-ray imaging. The grating-based phase-contrast setup was described in detail elsewhere37. 
Attenuation-based (gbCT), phase-contrast (gbPC-CT) and dark-field computed tomographic images were simul-
taneously obtained12,38, the latter were not considered in this study12,39.
Samples were imaged without contrast media. Detailed scan parameters can be found in Table 2. The effective 
pixel size was 100 × 100 μ m2. Three-dimensional reconstruction was done of each scan. For a better calibration 
of the quantitative HU and HUp values a circular PMMA rod was included in every sample14. Due to the highly 
experimental character of the imaging setup no speed or dose optimization was performed. The radiation dose for 
a full sample tomographic scan was 10–15 Gray. Images were recorded and stored as DICOM-data.
Clinical CT and MR-imaging. Unenhanced scans were recorded using a 64-slice clinical CT scanner 
(clinCT; Optima CT660, GE Healthcare). For quantitative measurements, calibration materials like water, air and 
70% ethanol were placed together with the samples in a small acrylic glass body phantom. Samples were meas-
ured with a tube voltage of 120 kVp and a tube current of 80–200 mAs with a slice thickness of 0.625 mm and a 
pitch of 0.531. The calculated effective pixel size was 400 × 400 μ m2 at a diameter of the field of view of 21 cm at a 
matrix of 512 × 512. After filtered back projection, multiplanar reconstructions (coronal, sagittal) were calculated 
with a slice thickness of 1 mm and an increment of 0.7 mm.
The same samples were examined using a 3T MRI (MAGNETOM Skyra, Siemens Medical Solutions) placed 
in a 16-channel hand wrist coil. T1 and T2-weighted sequences with and without fat-saturation as well as suscep-
tibility weighted images (SWI) were acquired in transverse and coronal directions without additional contrast 
media (Table 3).
Histology. Formalin-fixed samples were cut into 5-mm slices and embedded in hot paraffin wax. 
Representative tissue sections were cut into 5 μ m sample sections and stained with hematoxylin and eosin (HE) 
using standard protocols.
An average of 10–12 histological slices were produced for each sample. Histological workup was performed 
by an experienced pathologist (V.M.). The diagnoses of the RCC subtypes was made based on microscopic eval-
uation according to histopathological diagnostic guidelines40. The diagnosis of a chromophobe RCC required 
further application of immunochemistry (Hale’s staining). Additionally, tumor components were classified as 
calcification, necrosis, hyalinization, hemorrhage, fibrous strands, pseudocapsules and fat.
Imaging and Quantitative analysis. All images were analyzed using a 32-bit image open access viewer 
(OsiriX 5.8; Apple Inc.) by one experienced radiologist (5+ years of experience) blinded to histopathological 
diagnoses.
First, sensitivity for the separation of normal kidney from tumor tissue was qualitatively and quantitatively 
evaluated. Second, images were manually matched to the corresponding histological slices (10–12 for each sam-
ple) using features such as fat, calcifications or tumor outline. The visual detection of calcifications, hemorrhage, 
pseudocapsules, fibrose strands, necrosis or hyalinization in the different imaging modalities corresponding to 
the matched histological slices as reference standard was assessed by the radiologist and pathologist in consensus. 
Voltage 40 kVp
Number of projections 800 over 360°
Number of phase steps 11
Exposure per phase step 3 s
Total scan time 11, 5 h for 2 cm of sample
Average sample height 6 cm (range 4 to 8 cm)
Table 2.  Technical parameters for grating-based X-ray imaging.
Sequence T1-w VIBE ± FS T2-w TSE ± FS SWI
Orientation transverse coronal transverse coronal transverse
TR (ms) 11.5 12.83 6890 3620 27
TE (− FS/+ FS) (ms) 3.69/4.92 4.41/5.64 44 59 20
FA 10° 10° 150° 150° —
FOV (mm) 200 200 200 180 204
Voxel size (mm3) 0.4 × 0.4 × 1.0 0.3 × 0.3 × 0.7 0.5 × 0.5 × 1.0 0.4 × 0.4 × 1.0 0.8 × 0.8 × 2.0
Table 3.  Technical parameters for sample imaging in 3 T MRI. VIBE – Volumetric interpolated brain 
examination; TSE – Turbo spin echo; FS – fat saturation; SWI – susceptibility weighted imaging; TR – repetition 
time; TE – echo time; FA – flip angle; FOV – field of view.
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The sensitivity to detect tumorous tissue in the different imaging modalities was calculated as the fraction of 
detected tumors compared to the histological findings.
Third, Phase-contrast Hounsfield units (HUp) were quantified14,20 for all kidney samples (n = 23) by placing 
regions of interest (ROIs). In each sample, 10–12 ROIs were placed on gbPC-CT and clinical CT images either 
encircling the entire tumor or individual tissue components, excluding calcification areas or macroscopic fat. 
Delineation was done in comparison to the corresponding histological sections in consensus of the radiologist 
and pathologist. Quantitative values of normal kidney parenchyma were calculated by placing ROIs in cortical 
and medullary regions of healthy human kidney samples (n = 3) and normal kidney parenchyma adherent to 
RCCs (n = 6).
Statistical Data Analysis. Statistical analysis was performed using SPSS (IBM SPSS 23.0, SPSS Inc). Mean 
values and standard deviations of HUp as well as independent t-tests were calculated using Excel (Excel 2008; 
Microsoft Inc.). A p-value of less than 0.05 indicated a statistically significant difference.
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